These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 28838692)

  • 21. Synthesis and biological evaluation of novel isoxazoles and triazoles linked 6-hydroxycoumarin as potent cytotoxic agents.
    Shakeel-u-Rehman ; Masood-ur-Rahman ; Tripathi VK; Singh J; Ara T; Koul S; Farooq S; Kaul A
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4243-6. PubMed ID: 25088398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential anticancer agents. I. Synthesis of isoxazole moiety containing quinazoline derivatives and preliminarily in vitro anticancer activity.
    Yong JP; Lu CZ; Wu X
    Anticancer Agents Med Chem; 2015; 15(1):131-6. PubMed ID: 25142319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and biological activity of new arenediyne-linked isoxazolidines.
    Romeo R; Navarra M; Giofrè SV; Carnovale C; Cirmi S; Lanza G; Chiacchio MA
    Bioorg Med Chem; 2014 Jul; 22(13):3379-85. PubMed ID: 24835789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New Ferrocene Formates Bearing Isoxazole Moieties: Synthesis, Characterization, X-ray Crystallography, and Preliminarily Cytotoxicity against A549, HCT116, and MCF-7 Cell Lines.
    Yong J; Lu C; Yang M; Wu X
    Curr Pharm Des; 2022; 28(34):2835-2841. PubMed ID: 35996233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, in vitro cytotoxicity and apoptosis inducing study of 2-aryl-3-nitro-2H-chromene derivatives as potent anti-breast cancer agents.
    Rahmani-Nezhad S; Safavi M; Pordeli M; Ardestani SK; Khosravani L; Pourshojaei Y; Mahdavi M; Emami S; Foroumadi A; Shafiee A
    Eur J Med Chem; 2014 Oct; 86():562-9. PubMed ID: 25216378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis and evaluation of novel levoglucosenone derivatives as promising anticancer agents.
    Tsai YH; Borini Etichetti CM; Cicetti S; Girardini JE; Spanevello RA; Suárez AG; Sarotti AM
    Bioorg Med Chem Lett; 2020 Jul; 30(14):127247. PubMed ID: 32527547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of diethyl 2,5-diaminothiophene-3,4-dicarboxylate derivatives as potent anticancer and antimicrobial agents and screening of anti-diabetic activity: synthesis and in vitro biological evaluation. Part 1.
    Bozorov K; Ma HR; Zhao JY; Zhao HQ; Chen H; Bobakulov K; Xin XL; Elmuradov B; Shakhidoyatov K; Aisa HA
    Eur J Med Chem; 2014 Sep; 84():739-45. PubMed ID: 25064350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and structure-activity relationships of pyridinyl-1H-1,2,3-triazolyldihydroisoxazoles as potent inhibitors of tubulin polymerization.
    Suman P; Murthy TR; Rajkumar K; Srikanth D; Dayakar Ch; Kishor C; Addlagatta A; Kalivendi SV; Raju BC
    Eur J Med Chem; 2015 Jan; 90():603-19. PubMed ID: 25499929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of Isoxazole Moiety Containing Thieno[2,3-d]pyrimidine Derivatives and Preliminarily in vitro Anticancer Activity (Part II).
    Yong J; Lu C; Wu X
    Anticancer Agents Med Chem; 2015; 15(9):1148-55. PubMed ID: 25742095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytotoxic and antimicrobial evaluations of novel apoptotic and anti-angiogenic spiro cyclic 2-oxindole derivatives of 2-amino-tetrahydroquinolin-5-one.
    Ghozlan SA; Mohamed MF; Ahmed AG; Shouman SA; Attia YM; Abdelhamid IA
    Arch Pharm (Weinheim); 2015 Feb; 348(2):113-24. PubMed ID: 25664629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 10-N-heterocylic aryl-isoxazole-amides (AIMs) have robust anti-tumor activity against breast and brain cancer cell lines and useful fluorescence properties.
    Weaver MJ; Stump S; Campbell MJ; Backos DS; Li C; Reigan P; Adams E; Beall HD; Natale NR
    Bioorg Med Chem; 2020 Nov; 28(22):115781. PubMed ID: 33038788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and anticancer activity of novel spiro-isoxazoline and spiro-isoxazolidine derivatives of α-santonin.
    Khazir J; Singh PP; Reddy DM; Hyder I; Shafi S; Sawant SD; Chashoo G; Mahajan A; Alam MS; Saxena AK; Arvinda S; Gupta BD; Kumar HM
    Eur J Med Chem; 2013 May; 63():279-89. PubMed ID: 23501113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis, biological evaluation and molecular docking studies of novel 3-aryl-4-anilino-2H-chromen-2-one derivatives targeting ERα as anti-breast cancer agents.
    Luo G; Chen M; Lyu W; Zhao R; Xu Q; You Q; Xiang H
    Bioorg Med Chem Lett; 2017 Jun; 27(12):2668-2673. PubMed ID: 28460819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and cytotoxicity evaluation of oleanolic acid derivatives.
    Hao J; Liu J; Wen X; Sun H
    Bioorg Med Chem Lett; 2013 Apr; 23(7):2074-7. PubMed ID: 23434227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, antimicrobial and anti-cancer activities of some new N-ethyl, N-benzyl and N-benzoyl-3-indolyl heterocycles.
    El-Sawy ER; Mandour AH; Mahmoud K; Islam IE; Abo-Salem HM
    Acta Pharm; 2012 Jun; 62(2):157-79. PubMed ID: 22750815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flavokawain derivative FLS induced G2/M arrest and apoptosis on breast cancer MCF-7 cell line.
    Ali NM; Akhtar MN; Ky H; Lim KL; Abu N; Zareen S; Ho WY; Alan-Ong HK; Tan SW; Alitheen NB; Ismail JB; Yeap SK; Kamarul T
    Drug Des Devel Ther; 2016; 10():1897-907. PubMed ID: 27358555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anticancer phytochemical analogs 37: synthesis, characterization, molecular docking and cytotoxicity of novel plumbagin hydrazones against breast cancer cells.
    Dandawate P; Ahmad A; Deshpande J; Swamy KV; Khan EM; Khetmalas M; Padhye S; Sarkar F
    Bioorg Med Chem Lett; 2014 Jul; 24(13):2900-4. PubMed ID: 24835626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and biological evaluation of 3,5-diaryl isoxazoline/isoxazole linked 2,3-dihydroquinazolinone hybrids as anticancer agents.
    Kamal A; Bharathi EV; Reddy JS; Ramaiah MJ; Dastagiri D; Reddy MK; Viswanath A; Reddy TL; Shaik TB; Pushpavalli SN; Bhadra MP
    Eur J Med Chem; 2011 Feb; 46(2):691-703. PubMed ID: 21194809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis and antibreast cancer MCF-7 cells biological evaluation of heterocyclic analogs of resveratrol.
    Du C; Dong MH; Ren YJ; Jin L; Xu C
    J Asian Nat Prod Res; 2017 Sep; 19(9):890-902. PubMed ID: 27809606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of new secretory phospholipase A2-inhibitory indole containing isoxazole derivatives as anti-inflammatory and anticancer agents.
    Pedada SR; Yarla NS; Tambade PJ; Dhananjaya BL; Bishayee A; Arunasree KM; Philip GH; Dharmapuri G; Aliev G; Putta S; Rangaiah G
    Eur J Med Chem; 2016 Apr; 112():289-297. PubMed ID: 26907155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.